Metabotropic glutamate receptor 5 (mGluR5) regulates bladder nociception

Molecular Pain

Volumn 8, Issue , 2012, Pages

  Crock, Lara W ^a   Stemler, Kristina M ^a   Song, David G ^b   Abbosh, Philip ^a   Vogt, Sherri K ^a   Qiu, Chang Shen ^a   Lai, H Henry ^a   Mysorekar, Indira U ^a   Gereau IV, Robert W ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bladder; Metabotropic glutamate receptor; Nociception; Urinary tract infection; Visceromotor response

Indexed keywords

FENOBAM; METABOTROPIC RECEPTOR 5; IMIDAZOLE DERIVATIVE; METABOTROPIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLADDER DISTENSION; CONTROLLED STUDY; CYSTALGIA; FEMALE; HYPERALGESIA; INFLAMMATORY PAIN; INTERSTITIAL CYSTITIS; MOUSE; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI; VISCERAL PAIN; ANIMAL; BLADDER; C57BL MOUSE; CENTRAL NERVOUS SYSTEM; DRUG ANTAGONISM; DRUG EFFECT; ESCHERICHIA COLI; METABOLISM; MICROBIOLOGY; PATHOGENICITY; URODYNAMICS;

ANIMALS; CENTRAL NERVOUS SYSTEM; ESCHERICHIA COLI; FEMALE; IMIDAZOLES; MICE; MICE, INBRED C57BL; NOCICEPTION; RECEPTORS, METABOTROPIC GLUTAMATE; URINARY BLADDER; URINARY TRACT INFECTIONS; URODYNAMICS;

EID: 84858741515     PISSN: None     EISSN: 17448069     Source Type: Journal    
DOI: 10.1186/1744-8069-8-20     Document Type: Article

References (68)

1. Rosenberg MT, Page S, Hazzard MA. Prevalence of interstitial cystitis in a primary care setting. Urology 2007, 69:48-52. 10.1016/j.urology.2006.03.085, 17462479.
2. Berry SH, Elliott MN, Suttorp M, Bogart LM, Stoto MA, Eggers P, Nyberg L, Clemens JQ. Prevalence of symptoms of bladder pain syndrome/interstitial cystitis among adult females in the united states. J Urol 2011, 186:540-544. 10.1016/j.juro.2011.03.132, 21683389.
3. Warren JW, Brown J, Tracy JK, Langenberg P, Wesselmann U, Greenberg P. Evidence-based criteria for pain of interstitial cystitis/painful bladder syndrome in women. Urology 2008, 71:444-448. 10.1016/j.urology.2007.10.062, 2293273, 18342184.
4. Maggi CA, Lecci A, Santicioli P, Del Bianco E, Giuliani S. Cyclophosphamide-induced cystitis in rats: involvement of capsaicin-sensitive primary afferents. Agents Actions 1993, 38 Spec No:C28-30.
5. Lai HH, Qiu CS, Crock LW, Morales ME, Ness TJ, Gereau RW. Activation of spinal extracellular signal-regulated kinases (ERK) 1/2 is associated with the development of visceral hyperalgesia of the bladder. Pain 2011, 152:2117-2124. 10.1016/j.pain.2011.05.017, 21705143.
6. Westropp JL, Buffington CA. In vivo models of interstitial cystitis. J Urol 2002, 167:694-702. 10.1016/S0022-5347(01)69129-8, 11792956.
7. Saban MR, Saban R, Hammond TG, Haak-Frendscho M, Steinberg H, Tengowski MW, Bjorling DE. LPS-sensory peptide communication in experimental cystitis. Am J Physiol Renal Physiol 2002, 282:F202-F210.
8. Boudes M, Uvin P, Kerselaers S, Vennekens R, Voets T, De Ridder D. Functional characterization of a chronic cyclophosphamide-induced overactive bladder model in mice. Neurourol Urodyn 2011, 30:1659-1665. 10.1002/nau.21180, 21717507.
9. Dang K, Lamb K, Cohen M, Bielefeldt K, Gebhart GF. Cyclophosphamide-induced bladder inflammation sensitizes and enhances P2X receptor function in rat bladder sensory neurons. J Neurophysiol 2008, 99:49-59. 2659400, 17959738.
10. Bower JM, Eto DS, Mulvey MA. Covert operations of uropathogenic Escherichia coli within the urinary tract. Traffic 2005, 6:18-31. 10.1111/j.1600-0854.2004.00251.x, 2523259, 15569242.
11. Baerheim A, Hunskar S. Current management of uncomplicated acute cystitis in general practice. Tidsskr Nor Laegeforen 1997, 117:1304-1307.
12. Malterud K, Baerheim A. Peeing barbed wire Symptom experiences in women with lower urinary tract infection. Scand J Prim Health Care 1999, 17:49-53. 10.1080/028134399750002908, 10229994.
13. Mysorekar IU, Hultgren SJ. Mechanisms of uropathogenic Escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci USA 2006, 103:14170-14175. 10.1073/pnas.0602136103, 1564066, 16968784.
14. Mulvey MA, Lopez-Boado YS, Wilson CL, Roth R, Parks WC, Heuser J, Hultgren SJ. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science (New York, NY 1998, 282:1494-1497.
15. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002, 113(Suppl 1A):5-13.
16. Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol 2010, 7:653-660. 10.1038/nrurol.2010.190, 21139641.
17. Matsumoto G, Hisamitsu T, de Groat WC. Role of glutamate and NMDA receptors in the descending limb of the spinobulbospinal micturition reflex pathway of the rat. Neurosci Lett 1995, 183:58-61. 10.1016/0304-3940(94)11114-X, 7746488.
18. Yoshiyama M, de Groat WC. Supraspinal and spinal alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid and N-methyl-D-aspartate glutamatergic control of the micturition reflex in the urethane-anesthetized rat. Neuroscience 2005, 132:1017-1026. 10.1016/j.neuroscience.2005.01.041, 3118677, 15857706.
19. Kakizaki H, Yoshiyama M, Roppolo JR, Booth AM, De Groat WC. Role of spinal glutamatergic transmission in the ascending limb of the micturition reflex pathway in the rat. J Pharmacol Exp Ther 1998, 285:22-27.
20. Varney MA, Gereau RW. Metabotropic glutamate receptor involvement in models of acute and persistent pain: prospects for the development of novel analgesics. Curr Drug Targets CNS Neurol Disord 2002, 1:283-296. 10.2174/1568007023339300, 12769620.
21. Karim F, Bhave G, Gereau RW. Metabotropic glutamate receptors on peripheral sensory neuron terminals as targets for the development of novel analgesics. Mol Psychiatry 2001, 6:615-617. 10.1038/sj.mp.4000961, 11673787.
22. Bhave G, Karim F, Carlton SM, Gereau RW. Peripheral group I metabotropic glutamate receptors modulate nociception in mice. Nat Neurosci 2001, 4:417-423. 10.1038/86075, 11276233.
23. Walker K, Bowes M, Panesar M, Davis A, Gentry C, Kesingland A, Gasparini F, Spooren W, Stoehr N, Pagano A, et al. Metabotropic glutamate receptor subtype 5 (mGlu5) and nociceptive function. I. Selective blockade of mGlu5 receptors in models of acute, persistent and chronic pain. Neuropharmacology 2001, 40:1-9. 10.1016/S0028-3908(00)00113-1, 11077065.
24. Hudson LJ, Bevan S, McNair K, Gentry C, Fox A, Kuhn R, Winter J. Metabotropic glutamate receptor 5 upregulation in A-fibers after spinal nerve injury: 2-methyl-6-(phenylethynyl)-pyridine (MPEP) reverses the induced thermal hyperalgesia. J Neurosci 2002, 22:2660-2668.
25. Hu HJ, Alter BJ, Carrasquillo Y, Qiu CS, Gereau RW. Metabotropic glutamate receptor 5 modulates nociceptive plasticity via extracellular signal-regulated kinase-Kv4.2 signaling in spinal cord dorsal horn neurons. J Neurosci 2007, 27:13181-13191. 10.1523/JNEUROSCI.0269-07.2007, 18045912.
26. Young RL, Page AJ, O'Donnell TA, Cooper NJ, Blackshaw LA. Peripheral versus central modulation of gastric vagal pathways by metabotropic glutamate receptor 5. Am J Physiol Gastrointest Liver Physiol 2007, 292:G501-G511.
27. Lindstrom E, Brusberg M, Hughes PA, Martin CM, Brierley SM, Phillis BD, Martinsson R, Abrahamsson C, Larsson H, Martinez V, Blackshaw LA. Involvement of metabotropic glutamate 5 receptor in visceral pain. Pain 2008, 137:295-305. 10.1016/j.pain.2007.09.008, 17937975.
28. Bianchi R, Rezzani R, Borsani E, Rodella L. mGlu5 receptor antagonist decreases Fos expression in spinal neurons after noxious visceral stimulation. Brain Res 2003, 960:263-266. 10.1016/S0006-8993(02)03697-1, 12505681.
29. Page AJ, Young RL, Martin CM, Umaerus M, O'Donnell TA, Cooper NJ, Coldwell JR, Hulander M, Mattsson JP, Lehmann A, Blackshaw LA. Metabotropic glutamate receptors inhibit mechanosensitivity in vagal sensory neurons. Gastroenterology 2005, 128:402-410. 10.1053/j.gastro.2004.11.062, 15685551.
30. Hu Y, Dong L, Sun B, Guillon MA, Burbach LR, Nunn PA, Liu X, Vilenski O, Ford AP, Zhong Y, Rong W. The role of metabotropic glutamate receptor mGlu5 in control of micturition and bladder nociception. Neurosci Lett 2009, 450:12-17. 10.1016/j.neulet.2008.11.026, 19027050.
31. Montana MC, Cavallone LF, Stubbert KK, Stefanescu AD, Kharasch ED, Gereau RW. The metabotropic glutamate receptor subtype 5 antagonist fenobam is analgesic and has improved in vivo selectivity compared with the prototypical antagonist 2-methyl-6-(phenylethynyl)-pyridine. J Pharmacol Exp Ther 2009, 330:834-843. 10.1124/jpet.109.154138, 2729799, 19515968.
32. Castroman P, Ness TJ. Vigor of visceromotor responses to urinary bladder distension in rats increases with repeated trials and stimulus intensity. Neurosci Lett 2001, 306:97-100. 10.1016/S0304-3940(01)01886-9, 11403967.
33. Ness TJ, Lewis-Sides A, Castroman P. Characterization of pressor and visceromotor reflex responses to bladder distention in rats: sources of variability and effect of analgesics. J Urol 2001, 165:968-974. 10.1016/S0022-5347(05)66586-X, 11176524.
34. Ness TJ, Elhefni H. Reliable visceromotor responses are evoked by noxious bladder distention in mice. J Urol 2004, 171:1704-1708. 10.1097/01.ju.0000116430.67100.8f, 15017270.
35. Ness TJ, Richter HE, Varner RE, Fillingim RB. A psychophysical study of discomfort produced by repeated filling of the urinary bladder. Pain 1998, 76:61-69. 10.1016/S0304-3959(98)00023-2, 9696459.
36. Birder LA. Urothelial signaling. Auton Neurosci 2010, 153:33-40. 10.1016/j.autneu.2009.07.005, 2818048, 19666243.
37. Zhu CZ, Wilson SG, Mikusa JP, Wismer CT, Gauvin DM, Lynch JJ, Wade CL, Decker MW, Honore P. Assessing the role of metabotropic glutamate receptor 5 in multiple nociceptive modalities. Eur J Pharmacol 2004, 506:107-118. 10.1016/j.ejphar.2004.11.005, 15588730.
38. Porter RH, Jaeschke G, Spooren W, Ballard TM, Buttelmann B, Kolczewski S, Peters JU, Prinssen E, Wichmann J, Vieira E, et al. Fenobam: a clinically validated nonbenzodiazepine anxiolytic is a potent, selective, and noncompetitive mGlu5 receptor antagonist with inverse agonist activity. J Pharmacol Exp Ther 2005, 315:711-721. 10.1124/jpet.105.089839, 16040814.
39. Guarneri L, Poggesi E, Angelico P, Farina P, Leonardi A, Clarke DE, Testa R. Effect of selective antagonists of group I metabotropic glutamate receptors on the micturition reflex in rats. BJU Int 2008, 102:890-898. 10.1111/j.1464-410X.2008.07748.x, 18489527.
40. Larson JA, Ogagan PD, Chen G, Shen B, Wang J, Roppolo JR, de Groat WC, Tai C. Involvement of metabotropic glutamate receptor 5 in pudendal inhibition of nociceptive bladder activity in cats. J Physiol 2011, 589:5833-5843.
41. Hopkins WJ, Gendron-Fitzpatrick A, Balish E, Uehling DT. Time course and host responses to Escherichia coli urinary tract infection in genetically distinct mouse strains. Infect Immun 1998, 66:2798-2802. 108272, 9596750.
42. Cervero F, Laird JM. Visceral pain. Lancet 1999, 353:2145-2148. 10.1016/S0140-6736(99)01306-9, 10382712.
43. Robinson DR, Gebhart GF. Inside information: the unique features of visceral sensation. Mol Interv 2008, 8:242-253. 10.1124/mi.8.5.9, 2732716, 19015388.
44. Gebhart GF. Pathobiology of visceral pain: molecular mechanisms and therapeutic implications IV. Visceral afferent contributions to the pathobiology of visceral pain. Am J Physiol Gastrointest Liver Physiol 2000, 278:834-838.
45. Gebhart GF. Descending modulation of pain. Neurosci Biobehav Rev 2004, 27:729-737. 10.1016/j.neubiorev.2003.11.008, 15019423.
46. Kolber BJ, Montana MC, Carrasquillo Y, Xu J, Heinemann SF, Muglia LJ, Gereau RW. Activation of metabotropic glutamate receptor 5 in the amygdala modulates pain-like behavior. J Neurosci 2010, 30:8203-8213. 10.1523/JNEUROSCI.1216-10.2010, 2898903, 20554871.
47. Walker K, Reeve A, Bowes M, Winter J, Wotherspoon G, Davis A, Schmid P, Gasparini F, Kuhn R, Urban L. mGlu5 receptors and nociceptive function II. mGlu5 receptors functionally expressed on peripheral sensory neurones mediate inflammatory hyperalgesia. Neuropharmacology 2001, 40:10-19. 10.1016/S0028-3908(00)00114-3, 11077066.
48. Fisher K, Lefebvre C, Coderre TJ. Antinociceptive effects following intrathecal pretreatment with selective metabotropic glutamate receptor compounds in a rat model of neuropathic pain. Pharmacol Biochem Behav 2002, 73:411-418. 10.1016/S0091-3057(02)00832-8, 12117596.
49. Varner AE. Beneficial effect of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with asthma during viral infection. J Infect Dis 2002, 186:723-724.
50. Lu YM, Jia Z, Janus C, Henderson JT, Gerlai R, Wojtowicz JM, Roder JC. Mice lacking metabotropic glutamate receptor 5 show impaired learning and reduced CA1 long-term potentiation (LTP) but normal CA3 LTP. J Neurosci 1997, 17:5196-5205.
51. Bradbury MJ, Campbell U, Giracello D, Chapman D, King C, Tehrani L, Cosford ND, Anderson J, Varney MA, Strack AM. Metabotropic glutamate receptor mGlu5 is a mediator of appetite and energy balance in rats and mice. J Pharmacol Exp Ther 2005, 313:395-402.
52. Evans MS, Reid KH, Sharp JB. Dimethylsulfoxide (DMSO) blocks conduction in peripheral nerve C fibers: a possible mechanism of analgesia. Neurosci Lett 1993, 150:145-148. 10.1016/0304-3940(93)90522-M, 8469412.
53. Hooton TM, Stamm WE. Diagnosis and treatment of uncomplicated urinary tract infection. Infect Dis Clin North Am 1997, 11:551-581. 10.1016/S0891-5520(05)70373-1, 9378923.
54. Rudick CN, Billips BK, Pavlov VI, Yaggie RE, Schaeffer AJ, Klumpp DJ. Host-pathogen interactions mediating pain of urinary tract infection. J Infect Dis 2010, 201:1240-1249. 10.1086/651275, 2841043, 20225955.
55. Neugebauer V, Li W, Bird GC, Bhave G, Gereau RW. Synaptic plasticity in the amygdala in a model of arthritic pain: differential roles of metabotropic glutamate receptors 1 and 5. J Neurosci 2003, 23:52-63.
56. Dolan S, Kelly JG, Monteiro AM, Nolan AM. Up-regulation of metabotropic glutamate receptor subtypes 3 and 5 in spinal cord in a clinical model of persistent inflammation and hyperalgesia. Pain 2003, 106:501-512. 10.1016/j.pain.2003.09.017, 14659534.
57. Foxman B, Brown P. Epidemiology of urinary tract infections: transmission and risk factors, incidence, and costs. Infect Dis Clin North Am 2003, 17:227-241. 10.1016/S0891-5520(03)00005-9, 12848468.
58. Zhang L, Foxman B. Molecular epidemiology of Escherichia coli mediated urinary tract infections. Front Biosci 2003, 8:e235-e244. 10.2741/1007, 12456300.
59. Ferraguti F, Shigemoto R. Metabotropic glutamate receptors. Cell Tissue Res 2006, 326:483-504. 10.1007/s00441-006-0266-5, 16847639.
60. Li W, Neugebauer V. Differential roles of mGluR1 and mGluR5 in brief and prolonged nociceptive processing in central amygdala neurons. J Neurophysiol 2004, 91:13-24.
61. Jia H, Rustioni A, Valtschanoff JG. Metabotropic glutamate receptors in superficial laminae of the rat dorsal horn. J Comp Neurol 1999, 410:627-642. 10.1002/(SICI)1096-9861(19990809)410:4<627::AID-CNE9>3.0.CO;2-8, 10398053.
62. Valerio A, Rizzonelli P, Paterlini M, Moretto G, Knopfel T, Kuhn R, Memo M, Spano P. mGluR5 metabotropic glutamate receptor distribution in rat and human spinal cord: a developmental study. Neurosci Res 1997, 28:49-57. 10.1016/S0168-0102(97)01175-9, 9179880.
63. Karim F, Wang CC, Gereau RW. Metabotropic glutamate receptor subtypes 1 and 5 are activators of extracellular signal-regulated kinase signaling required for inflammatory pain in mice. J Neurosci 2001, 21:3771-3779.
64. Li Z, Ji G, Neugebauer V. Mitochondrial reactive oxygen species are activated by mGluR5 through IP3 and activate ERK and PKA to increase excitability of amygdala neurons and pain behavior. J Neurosci 2011, 31:1114-1127. 10.1523/JNEUROSCI.5387-10.2011, 3073477, 21248136.
65. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983, 16:109-110. 10.1016/0304-3959(83)90201-4, 6877845.
66. Ness TJ, Gebhart GF. Interactions between visceral and cutaneous nociception in the rat. I. Noxious cutaneous stimuli inhibit visceral nociceptive neurons and reflexes. J Neurophysiol 1991, 66:20-28.
67. Hung CS, Dodson KW, Hultgren SJ. A murine model of urinary tract infection. Nat Protoc 2009, 4:1230-1243. 10.1038/nprot.2009.116, 2963178, 19644462.
68. Lai HH, Boone TB, Yang G, Smith CP, Kiss S, Thompson TC, Somogyi GT. Loss of caveolin-1 expression is associated with disruption of muscarinic cholinergic activities in the urinary bladder. Neurochem Int 2004, 45:1185-1193. 10.1016/j.neuint.2004.06.016, 15380628.